Does AMISULPRIDE Cause Neuroleptic malignant syndrome? 141 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 141 reports of Neuroleptic malignant syndrome have been filed in association with AMISULPRIDE (Barhemsys). This represents 4.5% of all adverse event reports for AMISULPRIDE.
141
Reports of Neuroleptic malignant syndrome with AMISULPRIDE
4.5%
of all AMISULPRIDE reports
9
Deaths
105
Hospitalizations
How Dangerous Is Neuroleptic malignant syndrome From AMISULPRIDE?
Of the 141 reports, 9 (6.4%) resulted in death, 105 (74.5%) required hospitalization, and 41 (29.1%) were considered life-threatening.
Is Neuroleptic malignant syndrome Listed in the Official Label?
Yes, Neuroleptic malignant syndrome is listed as a known adverse reaction in the official FDA drug label for AMISULPRIDE.
What Other Side Effects Does AMISULPRIDE Cause?
Drug ineffective (665)
Weight increased (346)
Toxicity to various agents (305)
Suicide attempt (261)
Akathisia (252)
Extrapyramidal disorder (226)
Drug abuse (219)
Leukopenia (218)
Therapeutic product effect incomplete (200)
Off label use (191)
What Other Drugs Cause Neuroleptic malignant syndrome?
QUETIAPINE (1,756)
OLANZAPINE (1,748)
RISPERIDONE (1,258)
HALOPERIDOL (1,244)
ARIPIPRAZOLE (1,138)
CLOZAPINE (899)
LITHIUM (506)
LORAZEPAM (437)
PALIPERIDONE (355)
VALPROIC ACID (352)
Which AMISULPRIDE Alternatives Have Lower Neuroleptic malignant syndrome Risk?
AMISULPRIDE vs AMITRIPTYLINE
AMISULPRIDE vs AMITRIPTYLINE\PERPHENAZINE
AMISULPRIDE vs AMIVANTAMAB
AMISULPRIDE vs AMIVANTAMAB-VMJW
AMISULPRIDE vs AMLODIPINE